Assessing the Extended In-Use Stability of the Infliximab Biosimilar PF-06438179/GP1111 Following Preparation for Intravenous Infusion
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-6901
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Assessing the Extended In-Use Stability of the Infliximab Biosimilar PF-06438179/GP1111 Following Preparation for Intravenous Infusion ; day:27 ; month:2 ; year:2019 ; pages:1-14
Drugs in R & D ; (27.2.2019), 1-14
- Creator
-
Vimpolsek, Maja
Gottar-Guillier, Marie
Rossy, Emmanuel
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40268-019-0264-1
- URN
-
urn:nbn:de:101:1-2019032413250556380716
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Vimpolsek, Maja
- Gottar-Guillier, Marie
- Rossy, Emmanuel
- SpringerLink (Online service)
Other Objects (12)
PF-06438179/GP1111: An Infliximab Biosimilar
Correction to: PF-06438179/GP1111: An Infliximab Biosimilar
Crystal Structures of PF-06438179/GP1111, an Infliximab Biosimilar
Nonclinical Evaluation of PF-06438179: A Potential Biosimilar to Remicade® (Infliximab)
Subcutaneous infliximab in Crohn’s disease patients with previous immunogenic failure of intravenous infliximab
Meropenem: continuous or extended infusion?
Analytical and Functional Similarity Assessment of ABP 710, a Biosimilar to Infliximab Reference Product
Predictors of infusion reactions during infliximab treatment in patients with arthritis
Incidence of Infusion Reactions and Clinical Effectiveness of Intravenous Golimumab Versus Infliximab in Patients with Rheumatoid Arthritis: The Real-World AWARE Study
In-Use Stability of SB12 (Eculizumab, Soliris Biosimilar) Diluted in Saline and Dextrose Infusion Solution after an Extended Storage Period
Intracranial hemodynamics during intravenous infusion of glyceryl trinitrate
Incidence and Management of Infusion Reactions to Infliximab in an Alternate Care Setting
PF-06438179/GP1111: An Infliximab Biosimilar
Correction to: PF-06438179/GP1111: An Infliximab Biosimilar
Crystal Structures of PF-06438179/GP1111, an Infliximab Biosimilar
Nonclinical Evaluation of PF-06438179: A Potential Biosimilar to Remicade® (Infliximab)
Subcutaneous infliximab in Crohn’s disease patients with previous immunogenic failure of intravenous infliximab
Meropenem: continuous or extended infusion?
Analytical and Functional Similarity Assessment of ABP 710, a Biosimilar to Infliximab Reference Product
Predictors of infusion reactions during infliximab treatment in patients with arthritis
Incidence of Infusion Reactions and Clinical Effectiveness of Intravenous Golimumab Versus Infliximab in Patients with Rheumatoid Arthritis: The Real-World AWARE Study
In-Use Stability of SB12 (Eculizumab, Soliris Biosimilar) Diluted in Saline and Dextrose Infusion Solution after an Extended Storage Period
Intracranial hemodynamics during intravenous infusion of glyceryl trinitrate
Incidence and Management of Infusion Reactions to Infliximab in an Alternate Care Setting
PF-06438179/GP1111: An Infliximab Biosimilar
Correction to: PF-06438179/GP1111: An Infliximab Biosimilar
Crystal Structures of PF-06438179/GP1111, an Infliximab Biosimilar
Nonclinical Evaluation of PF-06438179: A Potential Biosimilar to Remicade® (Infliximab)
Subcutaneous infliximab in Crohn’s disease patients with previous immunogenic failure of intravenous infliximab
Meropenem: continuous or extended infusion?
Analytical and Functional Similarity Assessment of ABP 710, a Biosimilar to Infliximab Reference Product
Predictors of infusion reactions during infliximab treatment in patients with arthritis
Incidence of Infusion Reactions and Clinical Effectiveness of Intravenous Golimumab Versus Infliximab in Patients with Rheumatoid Arthritis: The Real-World AWARE Study
In-Use Stability of SB12 (Eculizumab, Soliris Biosimilar) Diluted in Saline and Dextrose Infusion Solution after an Extended Storage Period
Intracranial hemodynamics during intravenous infusion of glyceryl trinitrate